Skip to main content
. Author manuscript; available in PMC: 2023 Apr 6.
Published in final edited form as: Health Aff (Millwood). 2021 Dec;40(12):1900–1908. doi: 10.1377/hlthaff.2021.00458

EXHIBIT 1.

Characteristics of US adult patients with incident kidney failure at treatment initiation, 2000–17

Characteristics Overall (2000–17) Period 1 (2000–05) Period 2 (2006–11) Period 3 (2012–17)
No. of incident patients 1,944,535 585,322 653,136 706,077
Age, mean years Age group (years), % 62.9 62.7 63.0 62.9
 18–44 12.5 13.4 12.4 11.9
 45–64 37.9 36.2 38.5 38.9
 65–74 24.7 24.6 23.5 25.9
 75 or older 24.9 25.8 25.7 23.4
Female, % 43.8 45.7 43.6 42.3
Race and ethnicity, %
 White, non-Hispanic 53.9 55.0 53.5 53.3
 Black, non-Hispanic 27.6 28.2 28.1 26.5
 Hispanic or Latino 12.9 11.2 13.0 14.2
 Other, non-Hispanic 5.6 5.6 5.3 6.1
Insurance type, %
 Medicare 45.4 43.5 43.5 48.7
 Private 14.8 15.1 16.4 13.1
 Dual eligible 13.3 12.9 13.1 13.7
 Medicaid 12.3 11.7 12.3 12.8
 VA or other 7.3 9.0 7.1 6.2
 Uninsured 6.9 7.8 7.6 5.5
Primary cause of kidney failure, %
 Diabetes 45.7 45.0 44.8 47.1
 Hypertension 26.9 25.1 27.1 28.2
 Other 27.4 29.9 28.1 24.7
eGFR, mean 9.8 9.0 10.3 10.0
Preemptive transplant, % 2.0 1.8 2.3 2.0

SOURCE Authors’ analyses of Medical Evidence Report data (form CMS 2728), 2000–17. NOTES Some group percentages may exceed 100 percent because of rounding. Authors used Pearson’s chi-square tests to compare changes in each characteristic by period; overall estimates are presented for reference. p < 0.001 for all comparisons. Dual eligible is eligible for both Medicare and Medicaid. VA is Veterans Affairs. eGFR is estimated glomerular filtration rate, a measure of normal kidney function; numbers below 15 indicate kidney failure.